Long-acting bronchodilator initiation in COPD and the risk of adverse cardio-pulmonary events: A population-based comparative safety study.
CONCLUSION: COPD treatment initiation with tiotropium compared with LABA does not increase cardiovascular risk in the first year of treatment. The risk of pneumonia is higher with LABA, a likely effect of the inhaled corticosteroids present in many LABA inhalers used in real world clinical practice.
PMID: 27554300 [PubMed - as supplied by publisher]
Source: Chest - Category: Respiratory Medicine Authors: Suissa S, Dellaniello S, Ernst P Tags: Chest Source Type: research
More News: Arrhythmia | Cardiology | Cardiovascular | Chronic Obstructive Pulmonary | Corticosteroid Therapy | Heart | Heart Attack | Heart Failure | Pneumonia | Respiratory Medicine | Spiriva | Stroke | Study | Tiotropium